ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,833Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 1692

$709K Total Retail Price of All Prescriptions

Rank: 108 out of 1692

412 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,282 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 671 241 S3 1 6
OMEPRAZOLE 468 277 2 5
LISINOPRIL 370 190 3 2
WARFARIN SODIUM 346 318 4 14
SIMVASTATIN 344 218 5 1
LEVOTHYROXINE SODIUM 333 202 6 4
GABAPENTIN 317 150 7 13
FUROSEMIDE 313 215 8 7
METOPROLOL TARTRATE 263 185 9 10
METFORMIN HCL 219 107 10 8
TRAMADOL HCL 213 72 11 16
AMLODIPINE BESYLATE 199 164 12 3
LOSARTAN POTASSIUM 177 119 13 17
MELOXICAM 170 94 14 41
POTASSIUM CHLORIDE 166 112 15 20
NEXIUM 151 35 16 25
ZETIA 149 56 17 68
ZOLPIDEM TARTRATE 148 44 18 23
HYDROCHLOROTHIAZIDE 142 56 19 9
CARISOPRODOL 130 0 R 20 137
ATENOLOL 129 65 21 15
PRAVASTATIN SODIUM 113 76 22 12
ATORVASTATIN CALCIUM 113 62 22 11
COMBIVENT 107 41 24 141
LOVAZA 107 62 24 176
ISOSORBIDE MONONITRATE ER 105 94 26 55
TRIAMTERENE-HCTZ 104 58 27 61
CARVEDILOL 104 79 27 24
PROAIR HFA 98 39 29 40
WELCHOL 96 40 30 217
RANITIDINE HCL 96 49 30 28
SINGULAIR 94 54 32 79
PANTOPRAZOLE SODIUM 93 26 33 39
TRICOR 89 37 34 112
CYCLOBENZAPRINE HCL 87 12 R 35 54
DIGOXIN 87 87 35 85
GEMFIBROZIL 86 43 37 98
IBUPROFEN 85 28 38 78
ENDOCET 84 33 S2 39 132
JANUMET 83 38 40 202
SPIRIVA 82 18 41 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 18 42 19
FENOFIBRATE 81 37 42 63
LOVASTATIN 80 65 44 37
AZITHROMYCIN 80 43 44 34
JANUVIA 79 51 46 72
CLOPIDOGREL 79 38 46 43
DILTIAZEM 24HR CD 78 50 48 96
METOPROLOL SUCCINATE 78 69 48 18
CITALOPRAM HBR 77 62 50 21
CRESTOR 68 41 51 26
CYMBALTA 68 24 51 51
CEPHALEXIN 66 47 53 89
POLYETHYLENE GLYCOL 3350 66 57 53 64
ENALAPRIL MALEATE 61 41 55 71
GLIMEPIRIDE 58 50 56 32
METFORMIN HCL ER 56 50 57 49
BYSTOLIC 55 43 58 129
GLIPIZIDE 55 49 58 47
TAMSULOSIN HCL 54 37 60 31
CLONIDINE HCL 53 28 61 46
DONEPEZIL HCL 51 51 62 29
NASONEX 51 0 62 245
SERTRALINE HCL 51 46 62 22
ESCITALOPRAM OXALATE 50 34 65 76
FINASTERIDE 50 47 65 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.